PLACIDYL CAP 200MG DIN 00000019
Health Canada record
| Active ingredient(s) | ETHCHLORVYNOL 200 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| Class | Human |
| ATC | N05CM08 ETHCHLORVYNOL |
| Original market date | 31-Dec-1956 |
| Current status date | 10-Jun-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Abbott Laboratories Co. — licence 3-002635, currently licensed, last inspection rating C (2024-09-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ETHCHLORVYNOL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00000027 | PLACIDYL CAP 500MG | ABBOTT LABORATORIES, LIMITED | Capsule | ETHCHLORVYNOL 500 MG | Cancelled Post Market |
| 00228893 | PLACIDYL CAP 750MG | ABBOTT LABORATORIES, LIMITED | Capsule | ETHCHLORVYNOL 750 MG | Cancelled Post Market |
International API supply for ETHCHLORVYNOL
0 active FDA Drug Master Files.
Request a quote for PLACIDYL CAP 200MG